Navigation Links
InterMune Announces Issuance of U.S. Patent for ITMN-191
Date:2/19/2009

tment discontinuation.

In November 2008, InterMune, Roche and Pharmasset, Inc. initiated the first all-oral combination study of direct anti-virals in the absence of interferon or ribavirin, known as the INFORM-1 study. That study has completed the first dose cohort. Results of INFORM-1 are expected to be reported at a major medical conference in the second quarter of 2009.

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has a pipeline portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The pulmonology portfolio includes the Phase 3 program, CAPACITY, which is evaluating pirfenidone as a possible therapeutic candidate for the treatment of patients with IPF, RECAP, an open-label extension study from CAPACITY and a research program focused on small molecules for the treatment of pulmonary disease. The hepatology portfolio includes the HCV protease inhibitor compound ITMN-191 (referred to as R7227 at Roche) in Phase 1b, a second-generation HCV protease inhibitor research program, and a research program evaluating new targets in hepatology. For additional information about InterMune and its R&D pipeline, please visit www.intermune.com.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of section 21E of the Securities Exchange Act of 1934, as amended, that reflect InterMune's judgment and involve risks and uncertainties as of the date of this release, including without limitation the statements related to anticipated product development timelines and the likelihood of regulatory success. All forward-looking statements and other information included in this press release are based on inf
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. InterMune to Present at Thomas Weisel and Bear Stearns Healthcare Conferences
2. InterMune Announces Proposed Public Offering of Common Stock
3. InterMune Announces Pricing of $68 Million Public Offering of Common Stock
4. InterMune Announces Closing of Public Offering of Common Stock
5. InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance
6. InterMune to Present at the SIGnificant Options in Healthcare Conference
7. Evotec Expands Collaboration With InterMune
8. Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
9. InterMune to Present at Deutsche Bank Health Care Conference
10. InterMune to Present at Bank of America Health Care Conference
11. InterMune to Present at Citigroup Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... 14 Dyadic International, Inc. (Pink Sheets: ... its collaboration with The Scripps Research Institute ("Scripps") ... re-annotate the genome of Dyadic,s patented and proprietary ... continuation of the successful relationship between the two ... engaged Scripps to annotate the C1 genome for ...
(Date:12/14/2009)... Lionbridge (Nasdaq: LIOX ) ... new, three-year master services agreement with a ... services that serve patients in approximately 100 ... the sole provider for translation of the ... training, human resources, legal, and corporate communications ...
(Date:12/14/2009)... - Results From a Survey Conducted by UCB Assessing ... Countries , , - A third of ... impacts their enjoyment of the festive season, ... shopping for gifts, preparing holiday ... difficult to do, - Nearly ...
(Date:12/11/2009)... Researchers have discovered a new explanation for differences in the ... of a certain gene, the more serious the handicap. The ... suspected that it is the amount of copies of the ... in the American Journal of Human Genetics , and ... Froyen connected to VIB, a life sciences research institute in ...
Breaking Biology Technology:Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4Amount of gene surplus determines severity of mental retardation in males 2
... /Xinhua-PRNewswire-FirstCall/ --,China Biologic Products, Inc. (OTC Bulletin ... of the leading plasma-based pharmaceutical companies,in the ... announced that on,August 6, 2008, the PRC,s ... China Biologic,s production facility in Taian City ...
... 4 Repligen Corporation,(Nasdaq: RGEN ) today ... research grants to support the development of new ... $1 million from the,Muscular Dystrophy Association (MDA) and ... the National Ataxia Foundation (NAF).,The grants will further ...
... experts on building sustainable cities -- urban leaders and ... Oct. 2008 for the landmark conference, Futuropolis 2058. ... urban developments and problems that will affect cities in ... on Einstein,s unified field theory, Michio Kaku, Ph.D., is ...
Other Biology Technology:China Biologic's Production Facility Renews GMP Certification 2China Biologic's Production Facility Renews GMP Certification 3Repligen Receives Research Grants to Support Friedreich's Ataxia Development Program 2Repligen Receives Research Grants to Support Friedreich's Ataxia Development Program 3Repligen Receives Research Grants to Support Friedreich's Ataxia Development Program 4Repligen Receives Research Grants to Support Friedreich's Ataxia Development Program 5Singapore to hold international 'pow-wow' 2Singapore to hold international 'pow-wow' 3
(Date:12/15/2009)... an enormous emotional and economic toll on society. It ... currents each year in U.S. waters and it,s likely that ... A serious disconnect exists between rip current research and ... tides and undertows, and more importantly, most people do not ... rip current. , The goal of the Rip Current Symposium ...
(Date:12/14/2009)... -- Researchers at Rice University and Baylor College of ... be tracked in real time with MRI as it ... fluorescent dye and kills them with heat. The all-in-one ... growing field called "theranostics" that develops technologies physicians can ... procedure. , The research is available online in the ...
(Date:12/14/2009)... Engineering Society (BMES) have founded a new journal ... CVET is a forum for research on ... The first issue of the new quarterly journal will ... publications at Springer, Annals of Biomedical Engineering ... Cardiovascular Engineering and Technology will present a wide ...
Breaking Biology News(10 mins):Tracking new cancer-killing particles with MRI 2Biomedical Engineering Society's new journal to be published by Springer 2Major League Baseball Pitchers John Smoltz and Derek Lowe Help Raise Awareness Throughout Prostate Cancer Awareness Month 55825 1Major League Baseball Pitchers John Smoltz and Derek Lowe Help Raise Awareness Throughout Prostate Cancer Awareness Month 55825 2Major League Baseball Pitchers John Smoltz and Derek Lowe Help Raise Awareness Throughout Prostate Cancer Awareness Month 55825 3Major League Baseball Pitchers John Smoltz and Derek Lowe Help Raise Awareness Throughout Prostate Cancer Awareness Month 55825 4Peregrine Pharmaceuticals to Present at the Rodman 26 Renshaw 11th Annual Healthcare Conference 13760 1Peregrine Pharmaceuticals to Present at the Rodman 26 Renshaw 11th Annual Healthcare Conference 13760 2Mark W Parrish Joins Mylans Board of Directors 13758 1Mark W Parrish Joins Mylans Board of Directors 13758 2
... rush to produce corn-based ethanol as a fuel alternative will ... Zone that kills fish and aquatic life, according to University ... study of its kind, Donner and Chris Kucharik of the ... the problem of nutrient pollution in a waterway. Their findings ...
... in China,s carbon dioxide (CO2) emissions is far outpacing ... gases much more difficult, according to a new analysis ... UC San Diego. , Previous estimates, including those used ... region that includes China will see a 2.5 to ...
... new light on a novel histone acetyltransferase protein complex ... acetyl functional group into histone proteins, a process by ... findings were posted to the Web site of Nature ... a future print edition of the journal. , ...
Other Biology News:US rush to produce corn-based ethanol will worsen 'dead zone' in Gulf of Mexico: UBC study 2New UC analysis shows alarming increase in expected growth of China's carbon dioxide emissions 2New UC analysis shows alarming increase in expected growth of China's carbon dioxide emissions 3Workman Lab characterizes novel regulator of chromosome function 2
... cells are used for heterologous protein expression in ... The S2 cell line was derived from a ... Drosophila melanogaster embryos (1). This ... without CO2 and is easily adapted to suspension ...
... in-troduced a new concept, namely production of proteins ... the T7 phage promoter, and (ii) at the ... number, The main advantage of our dual-control ex-pression ... the outstanding features of the pET vectors, but ...
... NTI allows you to store and manage ... in a secure central relational database. Storing ... an invaluable resource for clone tracking and ... for immediate analysis. LabShare software integrates seamlessly ...
... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
Biology Products: